Results 131 to 140 of about 7,033 (216)

Farber's Lipogranulomatosis: Multimodal Therapy With Tocilizumab and Consolidative HSCT Improves Assessment, and Long-Term Outcome. [PDF]

JIMD Rep
Lucas NCC, Horgan C, Mustafa O, Senthil S, Bonney D, Nataraj R, Fisher S, Tan C, Rust S, Jones SA, Hulley S, Wynn R.   +11 more
europepmc   +1 more source

Ceramide metabolism and cardiovascular risk factors: insights into therapeutic strategies. [PDF]

Front Cardiovasc Med
Yang S, Wu Y.
europepmc   +1 more source

Targeted analysis of sphingolipids and cytokines in plasma of dairy cows after calving reveals distinct impacts of systemic inflammation, ketosis, and mastitis. [PDF]

J Anim Sci Biotechnol
Lassallette E, Baysse AP, Gausseres B, Foucras G, Guerre P.   +4 more
europepmc   +1 more source

Acid ceramidase as a novel target for adiponectin receptor agonist to abrogate podocyte NLRP3 inflammasome activation and glomerular inflammation during obesity. [PDF]

J Pharmacol Exp Ther
Li G, Huang D, Kidd JM, Zou Y, Wu X, Zhang Y, Gehr TWB, Li N, Li PL.   +8 more
europepmc   +1 more source

Role of Canonical and Non-Canonical Sphingolipids and their Metabolic Enzymes in Bone Health. [PDF]

Curr Osteoporos Rep
Yamada C, Akkaoui J, Morozov A, Movila A.   +3 more
europepmc   +1 more source

Alkaline Ceramidase 3 [PDF]

, 2020
openaire   +1 more source

A Review Discussing Synthesis and Translational Studies of Medicinal Agents Targeting Sphingolipid Pathways. [PDF]

Biomolecules
Mateen S, Oman J, Haniyyah S, Sharma K, Aghazadeh-Habashi A, Pashikanti S.   +5 more
europepmc   +1 more source

Intestinal Neutral Ceramidase Deficiency Triggers Regulatory T Cell Response via Gd3 to Protect the Host from Intestinal Inflammation. [PDF]

Adv Sci (Weinh)
Xu Z, Lei C, Sriwastva MK, Wang T, Tuohongerbieke A, Song X, Noud C, Derkson S, Tan Y, Dryden G, McClain CJ, Deng Z.   +11 more
europepmc   +1 more source

Inhibition or genetic reduction of ASAH1/acid ceramidase restore α-synuclein clearance in mutant GBA1 dopamine neurons from Parkinson's patients. [PDF]

Hum Mol Genet
Kumar M, Feldman RA.
europepmc   +1 more source

Sphingolipid metabolism dysregulation: A cause for lung cancer development, progression, and resistance to therapies. [PDF]

Chin Med J Pulm Crit Care Med
Mao C.
europepmc   +1 more source